Clear Street Derivatives’s Aspire Biopharma Warrant ASBPW Stock Holding History

Clear Street Derivatives’s Portfolio ASBPW Stock Details ASBPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$4.74K	Hold	106,000	–	–	0.04%	23
2025 Q1	$7.18K	Hold	106,000	–	–	﹤0.01%	50
2024 Q4	$5.04K	Hold	106,000	–	–	﹤0.01%	67
2024 Q3	$4.48K	Hold	106,000	–	–	﹤0.01%	84
2024 Q2	$4.76K	Hold	106,000	–	–	﹤0.01%	93
2024 Q1	$3.19K	Buy	+106,000	New	+$4.14K	﹤0.01%	107

Other funds holding ASBPW

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Clear Street Derivatives's ASBPW Position: Q2 2025 in Review

Clear Street Derivatives held its Aspire Biopharma Warrant (ASBPW) position steady in Q2 2025 at 106,000 shares worth $4.74K. The position accounts for 0.04% of the portfolio, ranked #23.

Clear Street Derivatives first reported a position in ASBPW in Q1 2024 and has held it in 6 quarters since. The position peaked at $7.18K in Q1 2025. 29 funds tracked by Wall St. Rank hold ASBPW as of Q2 2025.

Clear Street Derivatives held 106,000 shares of Aspire Biopharma Warrant worth $4.74K as of Q2 2025.
Clear Street Derivatives left its Aspire Biopharma Warrant share count unchanged in Q2 2025.
Aspire Biopharma Warrant made up 0.04% of Clear Street Derivatives's portfolio in Q2 2025, its #23 holding.
Clear Street Derivatives first reported a position in Aspire Biopharma Warrant in Q1 2024 and has held it in 6 quarters since.
Clear Street Derivatives's Aspire Biopharma Warrant position peaked at $7.18K in Q1 2025.
29 funds tracked by Wall St. Rank held Aspire Biopharma Warrant as of Q2 2025.

Based on Clear Street Derivatives's 13F filing for Q2 2025, filed 13 Aug 2025.